Last Updated: November 8, 2026

FLURANDRENOLIDE Drug Patent Profile

Name: FLURANDRENOLIDE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Flurandrenolide, and when can generic versions of Flurandrenolide launch?

Flurandrenolide is a drug marketed by Chartwell Rx, Alpharma Us Pharms, Padagis Israel, and Teligent. and is included in five NDAs.

The generic ingredient in FLURANDRENOLIDE is flurandrenolide. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the flurandrenolide profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Flurandrenolide

A generic version of FLURANDRENOLIDE was approved as flurandrenolide by PADAGIS ISRAEL on August 30^th, 2016.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for FLURANDRENOLIDE?
What are the global sales for FLURANDRENOLIDE?
What is Average Wholesale Price for FLURANDRENOLIDE?

Summary for FLURANDRENOLIDE

US Patents:	0
Applicants:	4
NDAs:	5
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	48
Drug Prices:	Drug price information for FLURANDRENOLIDE
What excipients (inactive ingredients) are in FLURANDRENOLIDE?	FLURANDRENOLIDE excipients list
DailyMed Link:	FLURANDRENOLIDE at DailyMed

Drug patent expirations by year for FLURANDRENOLIDE

Pharmacology for FLURANDRENOLIDE

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

US Patents and Regulatory Information for FLURANDRENOLIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	FLURANDRENOLIDE	flurandrenolide	CREAM;TOPICAL	205342-001	Apr 13, 2016		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Padagis Israel	FLURANDRENOLIDE	flurandrenolide	LOTION;TOPICAL	207133-001	Aug 30, 2016		RX	No	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Alpharma Us Pharms	FLURANDRENOLIDE	flurandrenolide	LOTION;TOPICAL	087203-001	Apr 29, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.